Search Results - "JANSEN, Burkhard"

Refine Results
  1. 1

    Development and validation of a noninvasive 2-gene molecular assay for cutaneous melanoma by Gerami, Pedram, MD, Yao, Zuxu, PhD, Polsky, David, MD, PhD, Jansen, Burkhard, MD, Busam, Klaus, MD, Ho, Jonhan, MD, Martini, Mary, MD, Ferris, Laura K., MD, PhD

    “…Background Clinical and histopathologic assessment of pigmented skin lesions remains challenging even for experts. Differentiated and accurate noninvasive…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Hepatocytes convert to a fibroblastoid phenotype through the cooperation of TGF-β1 and Ha-Ras: steps towards invasiveness by Gotzmann, Josef, Huber, Heidemarie, Thallinger, Christiane, Wolschek, Markus, Jansen, Burkhard, Schulte-Hermann, Rolf, Beug, Hartmut, Mikulits, Wolfgang

    Published in Journal of cell science (15-03-2002)
    “…In hepatocarcinogenesis, it is an open question whether transforming growth factor (TGF)-β1 provides a tumor-suppressive or a tumor-promoting role. To address…”
    Get full text
    Journal Article
  4. 4

    Clusterin and IGFBPs as Antisense Targets in Prostate Cancer by GLEAVE, MARTIN, JANSEN, BURKHARD

    Published in Annals of the New York Academy of Sciences (01-12-2003)
    “…: The primary hurdle to improved survival of advanced prostate cancer is our failure to prevent or treat the tumor's progression to its lethal and untreatable…”
    Get full text
    Journal Article
  5. 5

    bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice by Jansen, Burkhard, Schlagbauer-Wadl, Hermine, Brown, Bob D, Bryan, Robert N, Van Elsas, Andrea, Müller, Markus, Wolff, Klaus, Eichler, Hans-Georg, Pehamberger, Hubert

    Published in Nature medicine (01-02-1998)
    “…Malignant melanoma is a prime example of cancers that respond poorly to various treatment modalities including chemotherapy. A number of chemotherapeutic…”
    Get full text
    Journal Article
  6. 6

    Antisense clusterin oligodeoxynucleotides increase the response of HER-2 gene amplified breast cancer cells to Trastuzumab by Biroccio, Annamaria, D'Angelo, Carmen, Jansen, Burkhard, Gleave, Martin E., Zupi, Gabriella

    Published in Journal of cellular physiology (01-08-2005)
    “…Clusterin (CLU) is a heterodimeric secreted glycoprotein implicated in several physiological and pathological processes including cancer. Although recent data…”
    Get full text
    Journal Article
  7. 7
  8. 8

    The Ras Inhibitor S-trans,trans-Farnesylthiosalicylic Acid Chemosensitizes Human Tumor Cells Without Causing Resistance by Gana-Weisz, Mali, Halaschek-Wiener, Julius, Jansen, Burkhard, Elad, Galit, Haklai, Ronit, Kloog, Yoel

    Published in Clinical cancer research (01-02-2002)
    “…Ras transformation requires Ras membrane anchorage, which is promoted by a farnesylcysteine carboxymethyl ester and by additional sequences specific to each…”
    Get full text
    Journal Article
  9. 9

    Mcl-1 Blocks Radiation-induced Apoptosis and Inhibits Clonogenic Cell Death by SKVARA, Hans, THALLINGER, Christiane, WACHECK, Volker, MONIA, Brett P, PEHAMBERGER, Hubert, JANSEN, Burkhard, SELZER, Edgar

    Published in Anticancer research (01-07-2005)
    “…Background: Anti-apoptotic Bcl-2 family proteins, such as Bcl-2 and Bcl-x, can modulate radio- and/or chemosensitivity of human malignancies. Since no…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    Mcl-1 Is a Novel Therapeutic Target for Human Sarcoma by Thallinger, Christiane, Wolschek, Markus F., Maierhofer, Helmut, Skvara, Hans, Pehamberger, Hubert, Monia, Brett P., Jansen, Burkhard, Wacheck, Volker, Selzer, Edgar

    Published in Clinical cancer research (15-06-2004)
    “…Purpose: Little is known about the role that Mcl-1, an antiapoptotic Bcl-2 family member, plays in solid tumor biology and susceptibility to anticancer…”
    Get full text
    Journal Article
  18. 18

    An Adhesive Patch-Based Skin Biopsy Device for Molecular Diagnostics and Skin Microbiome Studies by Yao, Zuxu, Moy, Ronald, Allen, Talisha, Jansen, Burkhard

    Published in Journal of drugs in dermatology (01-10-2017)
    “…A number of diagnoses in clinical dermatology are currently histopathologically confirmed and this image recognition-based confirmation generally requires…”
    Get more information
    Journal Article
  19. 19

    Utility of a Noninvasive 2-Gene Molecular Assay for Cutaneous Melanoma and Effect on the Decision to Biopsy by Ferris, Laura K, Jansen, Burkhard, Ho, Jonhan, Busam, Klaus J, Gross, Kenneth, Hansen, Doyle D, Alsobrook, 2nd, John P, Yao, Zuxu, Peck, Gary L, Gerami, Pedram

    Published in JAMA dermatology (Chicago, Ill.) (01-07-2017)
    “…Expression of long intergenic non-protein coding RNA 518 (LINC00518) and preferentially expressed antigen in melanoma (PRAME) genes, obtained via noninvasive…”
    Get more information
    Journal Article
  20. 20